Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2008 | 3 | 4 | 381-389
Tytuł artykułu

Chronic pain in urological diseases: a clinical review

Treść / Zawartość
Warianty tytułu
Języki publikacji
Chronic pain is the central problem in a variety of urological diseases. Pain is an unpleasant sensory and emotional experience associated with either actual or potential tissue damage, or described in terms of such damage. The aim of this research was to update knowledge about the ultrastructural, clinical, psychological and therapeutic aspects of chronic pain in urological diseases, in particular in chronic pelvic syndrome. In this paper we have revisited the most significant and discussed articles published in the last twenty five years, with particular references on the 2008 European Guidelines, searching key words (chronic pelvic pain syndrome, chronic pelvic pain, chronic prostatitis, interstitial cystitis, prostatodynia, urological disease) and data with a high level of evidence. The articles that we have analyzed show that pain is characterized by an initial tissue injury that can lead to sensitization, which is a decrease in the intensity of the stimulus needed to elicit a response by the nerve, involving the peripheral and central nervous systems. The chronic pain state is characterized by loss of inhibitory interneurons, establishment of aberrant excitatory synaptic connections and long-term potentiation of response due to changes in sensitivity of nerve synapses. Stress and hormones might also play a role in central sensitization. Pain also has a cognitive and emotional component. It is very difficult to treat, given the complex nature of the response and the interaction of physiological aspects

Opis fizyczny
  • Department of Urology, University “Federico II” of Naples, 80131, Naples, Italy,
  • Department of Urology, University “Federico II” of Naples, 80131, Naples, Italy
  • Department of Urology, University “Federico II” of Naples, 80131, Naples, Italy
  • Department of Urology, University “Federico II” of Naples, 80131, Naples, Italy
  • Department of Urology, University “Federico II” of Naples, 80131, Naples, Italy
  • Department of Urology, University “Federico II” of Naples, 80131, Naples, Italy
  • [1] Krieger J.N., Egan K.J., Ross S.O., Jacobs R., Berger R.E., Chronic pelvic pain represents the most prominent urogenital symptom of chronic prostatitis, Urology, 1996, 48, 715–721[Crossref]
  • [2] Propert K.J., McNaughton-Collins M., Leiby B.J., O’Leary M.P., Kusek J., Litwin M.S., and the Chronic Prostatitis Collaborative Research Network, A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort Study, J. Urol. 2006, 175, 619–23[Crossref]
  • [3] Nickel J.C., Interstitial cystitis: a chronic pelvic pain syndrome, Med. Clin. North. Am., 2004, 88, 467–82[Crossref]
  • [4] Weidner W., Fall M., Bjerklund Johansen T.E., Interstitial cystitis and prostatitis. Eur. Urol., 2002, 42–46
  • [5] Erickson B.R., Morgan K.C., Ordille S., Keay S.K., Xie S.X., Nonbladder related symptoms in patients with interstitial cystitis, J. Urol., 2001, 166, 557–562[Crossref]
  • [6] Parson C.L., Interstitial cystitis: a chronic disease with ever-increasing recognition and prevalence, J. Urol., 2005, 173–176
  • [7] Parson C.L., Prostatitis, interstitial cystitis, chronic pelvic pain and urethral syndrome share a common pathophysiology: lower urinary dysfunctional epithelium and potassium recycling, Urology, 2003, 69, 76–82
  • [8] Merskey H., Bogduk N., Classification of Chronic Pain. Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, IASP Press. 2002
  • [9] Foley K.M., Posner J.B., Pain and its management, In: Cecil Textbook of medicine. 18th edition. W. B. Saunders Company, 1988, 104–112
  • [10] Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., van Kerrebroeck P., Victor A., Wein A., The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society, Am. J. Obstet. Gynecol. 2002, 187, 116–126[Crossref]
  • [11] Rouviere H., Delmas A., In: Anatomie humaine (vol 2), Paris, Masson, 1985, 557
  • [12] Rauchenwald M., Desjardins C., Steers W.D., Autonomic innervation of the testis, Soc. Neurosci., 1993, 19, 509
  • [13] Tracey I., Mantyh P.W., The cerebral signature for pain perception and its modulation, Neuron., 2007, 55, 377–391[Crossref]
  • [14] Kingston J., Chadwick P., Meron D., Skinner T.C., A pilot randomized control trial investigating the effect of mindfulness practice on pain tolerance, psychological well-being, and physiological activity, J. Psychosom. Res., 2007, 62, 297–300[Crossref]
  • [15] Kabat-Zinn J., Lipworth L., Burney R., The clinical use of mindfulness meditation for the self-regulation of chronic pain. J. Behav. Med., 1985, 8, 163–190[Crossref]
  • [16] Chapman C.R., Pain perception and assessment, Minerva Anestesiol., 2005, 71, 413–417
  • [17] Grotle M., Vøllestad N.K., Brox J.I., Clinical course and impact of fear-avoidance beliefs in low back pain: prospective cohort study of acute and chronic low back pain: II., Spine, 2006, 31, 1038–1046[Crossref]
  • [18] Sloan T.J., Gupta R., Zhang W., Walsh D.A., Beliefs about the causes and consequences of pain in patients with chronic inflammatory or noninflammatory low back pain and in pain-free individuals, Spine, 2008, 33, 966–972[Crossref]
  • [19] Leonard M.T., Cano A., Pain affects spouses too: personal experience with pain and catastrophizing as correlates of spouse distress, Pain, 2006, 126, 139–146[Crossref]
  • [20] Tripp D.A., Nickel J.C., Wang Y., Litwin M.S., McNaughton-Collins M., Landis J.R., National Institutes of Health-Chronic Prostatitis Collaborative Research Network (NIH-CPCRN) Study Group, Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome, J. Pain, 2006, 7, 697–708[Crossref]
  • [21] Nickel J.C., Tripp D.A., Chuai S., Litwin M.S., McNaughton-Collins M., Landis J.R., et al, NIH-CPCRN Study Group, Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome, B.J.U. Int., 2008, 101, 59–64
  • [22] Aubin S., Berger R.E., Heiman J.R., Ciol M.A., The association between sexual function, pain, and psychological adaptation of men diagnosed with chronic pelvic pain syndrome type III, J. Sex. Med., 2008, 5, 657–667[Crossref]
  • [23] Heinberg L.J., Fisher B.J., Wesselmann U., Reed J., Haythornthwaite J.A.., Psychological factors in pelvic/urogenital pain: the influence of site of pain versus sex, Pain, 2004, 108, 88–94[Crossref]
  • [24] Smith K.B., Pukall C.F., Tripp D.A., Nickel J.C., Sexual and relationship functioning in men with chronic prostatitis/chronic pelvic pain syndrome and their partners, Arch. Sex. Behav., 2007, 36, 301–311[Crossref]
  • [25] Zhang W.Y., Li Wan Po A., Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review, Br. J. Obstet. Gynaecol., 1998, 105, 780–789
  • [26] McCormack K., Twycross R., COX-2-selective inhibitors and analgesia, Pain Clinical Updates, 2002, 10
  • [27] Jones S.F., Power I., Postoperative NSAIDs and COX-2 inhibitors: cardiovascular risks and benefits, Br. J. Anaesth., 2005, 95, 281–284
  • [28] Christie M.J., Vaughan C.W., Ingram S.L., Opioids, NSAIDs and 5-lipoxygenase inhibitors act synergistically in brain via arachidonic acid metabolism. Inflamm. Res., 1999, 48, 1–4[Crossref]
  • [29] McQuay H., Opioids in pain management, Lancet, 1999, 353, 2229–2232[Crossref]
  • [30] Baranowski A.P., Practical Applications and Procedures, In: Rice ASD, Warfield CA, Justins D, Eccleston C, eds. Pharmacological Diagnostic Tests in Clinical Pain Management. London: Arnold, 2003, 39–47
  • [31] Radbruch L., Grond S., Lehmann K.A., A risk-benefit assessment of tramadol in the management of pain, Drug Saf., 1996, 15, 8-29
  • [32] Pryle B.J., Grech H., Stoddart P.A., Carson R., O’Mahoney T., Reynolds F., Toxicity of norpethidine in sickle cell crisis, B.M.J. 1992, 304, 1478–1479
  • [33] Sagata K., Minami K., Yanagihara N., Shiraishi M., Toyohira Y., Ueno S., et al., Tramadol inhibits norepinephrine transporter function at desipraminebinding sites in cultured bovine adrenal medullary cells, Anesth. Analg., 2002, 94, 901–906[Crossref]
  • [34] Desmeules J.A., Piguet V., Collart L., Dayer P., Contribution of monoaminergic modulation to the analgesic effect of tramadol, Br. J. Clin. Pharmacol., 1996, 41, 7–12[Crossref]
  • [35] Hanno P.M., Amitriptyline in the treatment of interstitial cystitis, Urol. Clin. North. Am., 1994, 21, 89–91
  • [36] Pranikoff K., Constantino G., The use of amitriptyline in patients with urinary frequency and pain, Urology, 1998, 51(5A Suppl), 179–181[Crossref]
  • [37] Chew D.J., Buffington C.A., Kendall M.S., DiBartola S.P., Woodworth B.E., Amitriptyline treatment for severe recurrent idiopathic cystitis in cats, J. Am. Vet. Med. Assoc., 1998, 213, 1282–1286
  • [38] Rowbotham M., Harden N. Stacey B., Bernstein P., Magnus-Miller L., Gabapentin for the treatment ofpostherpetic neuralgia: a randomized controlled trial, JAMA,1998, 280, 1837–1842[Crossref]
  • [39] Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., et al., Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial, JAMA, 1998, 280, 1831–1836[Crossref]
  • [40] Price D.D., Mayer D.J., Mao J., Caruso F.S., NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance, J. Pain Symptom. Manage., 2000, 19, S7–11[Crossref]
  • [41] Mikkelsen S., Ilkjaer S., Brennum J., Borgbjerg F.M., Dahl J.B., The effect of naloxone on ketamineinduced effects on hyperalgesia and ketamine-induced side effects in humans, Anesthesiology, 1999, 90, 1539–1545[Crossref]
  • [42] Guirimand F., Dupont X., Brasseur L., Chauvin M., Bouhassira D., The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans, Anesth. Analg., 2000, 90, 408–414[Crossref]
  • [43] Laurido C., Pelissier T., Perez H., Flores F., Hernandez A., Effect of ketamine on spinal cord nociceptive transmission in normal and monoarthritic rats, Neuroreport, 2001, 12, 1551–1554[Crossref]
  • [44] Boas R.A., Covino B.G., Shahnarian A., Analgesic responses to i.v. lignocaine, Br. J. Anaesth., 1982, 54, 501–505[Crossref]
  • [45] Ferrante F.M., Paggioli J., Cherukuri S., Arthur G.R., The analgesic response to intravenous lidocaine in the treatment of neuropathic pain, Anesth. Analg., 1996, 82, 91–97[Crossref]
  • [46] Kovacs P., Gruber H., Piegger J., Bodner G., New, simple, ultrasound-guided infiltration of the pudendal nerve: ultrasonographic technique, Dis. Colon. Rectum., 2001, 44, 1381–1385[Crossref]
  • [47] McDonald J.S., Spigos D.G., Computed tomographyguided pudendal block for treatment of pelvic pain due to pudendal neuropathy, Obstet. Gynecol., 2000, 95, 306–309[Crossref]
  • [48] Kim S.W., Paick J.S., Ku J.H., Percutaneios posterior tibial nerve stimulation in patients with chronic pelvic pain: a preliminary study, Urol. Int., 2007, 78, 58–62[Crossref]
  • [49] Fall M., Lindstrom S., Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis, Urol. Clin. North Am., 1994, 21, 131–139
  • [50] Mulholland S.G., Hanno P., Parsons C.L., Sant G.R., Staskin D.R., Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study, Urology, 1990, 35, 552–558[Crossref]
  • [51] Holm-Bentzen M., Jacobsen F., Nerstrom B., Lose G., Kristensen J.K., Pedersen R.H., et al., A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease, J. Urol., 1987, 138, 503–507
  • [52] Ruud Bosch J.L., Groen J., Sacral nerve neuromodulation in the treatment of refractory motor urge incontinence, Curr. Opin. Urol., 2001, 11, 399–403[Crossref]
  • [53] Janknegt R.A., Hassouna M.M., Siegel S.W., Schmidt R.A., Gajewski J.B., Rivas D.A., et al., Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur. Urol. 2001, 39, 101–106[Crossref]
  • [54] Paszkiewicz E.J. Siegel S.W., Kirkpatrick C., Hinkel B., Keeisha J., Kirkemo A,. Sacral nerve stimulation in patients with chronic, intractable pelvic pain, Urology, 2001, 57(6 Suppl 1), 124[Crossref]
  • [55] Shaker H.S., Hassouna M., Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention,. J. Urol. 1998, 159, 1476–1478[Crossref]
  • [56] Kemler M.A., Barendse G.A.., van Kleef M., de Vet H.C., Rijks C.P., Furnee C.A., van den Wildenberg F.A., Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy, N. Engl. J. Med., 2000, 343, 618–624[Crossref]
  • [57] Chai T.C., Zhang C., Warren J.W., Keay S., Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis, Urology, 2000, 55, 643–646[Crossref]
  • [58] Maher C.F., Carey M.P., Dwyer P.L., Schluter PL. Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis, J. Urol., 2001, 165, 884–886[Crossref]
  • [59] Aboseif S., Tamaddon K., Chalfin S., Freedman S., Kaptein J., Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction, Urology, 2002, 60, 52–56[Crossref]
  • [60] Fric P., Probiotics and prebiotics - renaissance of a therapeutic principle, Cent. Eur. J. Med., 2007, 2, 237–270[Crossref]
  • [61] Weiner B.K. Spine update: the biopsychosocial model and spine care, Spine, 2008, 33, 219–223[Crossref]
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.